Literature DB >> 2891359

Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine.

C J Schmidt1, V L Taylor.   

Abstract

The psychotomimetic agent, methylenedioxymethamphetamine, produced a rapid, persistent and dose-dependent reduction in cortical tryptophan hydroxylase activity when administered acutely to rats. This effect did not occur in vitro and did not require N-demethylase activity in the whole animal. Kinetic analysis revealed the loss of enzyme activity to be due to an alteration in Vmax with no change in the affinity of the enzyme for either its cofactor or substrate. Coadministration of the serotonin (5-HT) uptake inhibitor, citalopram, only partially antagonized the loss of tryptophan hydroxylase activity 3 hr after methylenedioxymethamphetamine, but completely prevented the loss of cortical 5-HT. Recovery of enzyme activity did occur by 1 week if the neurotoxic effect of methylenedioxymethamphetamine was blocked by fluoxetine. The effect of methylenedioxymethamphetamine on 5-HT synthesis was not affected by pretreatment with alpha-methyl-p-tyrosine, reserpine or yohimbine. Ketanserine and methiothepin, 5-HT receptor antagonists, did partially block the methylenedioxymethamphetamine-induced loss of tryptophan hydroxylase activity, suggesting a possible role for neurotransmitter release in the acute effects of the drug on enzyme activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2891359     DOI: 10.1016/0006-2952(87)90566-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  30 in total

1.  Selective neurotoxins, chemical tools to probe the mind: the first thirty years and beyond.

Authors:  R M Kostrzewa
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

2.  Neurotoxicity and substance abuse: further fuel for regulatory dilemma.

Authors:  T Archer; T Palomo; R M Kostrzewa
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

3.  The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum.

Authors:  David M Thomas; Mariana Angoa Pérez; Dina M Francescutti-Verbeem; Mrudang M Shah; Donald M Kuhn
Journal:  J Neurochem       Date:  2010-09-06       Impact factor: 5.372

4.  L-tyrosine contributes to (+)-3,4-methylenedioxymethamphetamine-induced serotonin depletions.

Authors:  Joseph M Breier; Michael G Bankson; Bryan K Yamamoto
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

Review 5.  Causes and consequences of methamphetamine and MDMA toxicity.

Authors:  Maria S Quinton; Bryan K Yamamoto
Journal:  AAPS J       Date:  2006-05-12       Impact factor: 4.009

6.  Initial deficit and recovery of function after MDMA preexposure in rats.

Authors:  K A Brennan; S Schenk
Journal:  Psychopharmacology (Berl)       Date:  2005-12-16       Impact factor: 4.530

7.  High-dose MDMA does not result in long-term changes in impulsivity in the rat.

Authors:  Kathryn S Saadat; J Martin Elliott; A Richard Green; Paula M Moran
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

8.  MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature.

Authors:  Esther O'Shea; Laura Orio; Isabel Escobedo; Veronica Sanchez; Jorge Camarero; Alfred Richard Green; Maria Isabel Colado
Journal:  Br J Pharmacol       Date:  2006-06-12       Impact factor: 8.739

9.  Effect of repeated exposure to MDMA on the function of the 5-HT transporter as assessed by synaptosomal 5-HT uptake.

Authors:  Courtney Huff; Nirmal Bhide; Allen Schroering; Bryan K Yamamoto; Gary A Gudelsky
Journal:  Brain Res Bull       Date:  2013-01-12       Impact factor: 4.077

10.  Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices.

Authors:  J L Fitzgerald; J J Reid
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.